ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

AbbVie · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
rheumatoid-arthritis
rheumatoid arthritis (ra), atopic dermatitis (ad), ankylosing spondylitis (as), psoriatic arthritis (psa), rheumatoid arthritis, upadacitinib, rinvoq, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 915523
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.